The Utility of a Novel, Combined Biofeedback-Virtual Reality Device as Add-on Treatment for Chronic Migraine: A...

Area of Science:

• Neurology
• Medical Technology
• Digital Therapeutics

Background:

• Chronic migraine is a debilitating neurological condition with significant impact on quality of life.
• Current treatments often involve medication, with a need for non-pharmacological interventions.
• Biofeedback and virtual reality (VR) are emerging therapeutic modalities.

Purpose of the Study:

• To evaluate the efficacy of a combined biofeedback-virtual reality (VR) device for chronic migraine management.
• To assess the impact of frequent device use on headache frequency, medication use, and psychological factors.

Main Methods:

• A randomized, controlled pilot study involving 50 adults with chronic migraine.
• Participants were assigned to either a biofeedback-VR device group or a wait-list control group.
• Outcomes measured included headache days, acute analgesic use, depression, disability, stress, and insomnia at 12 weeks.

Main Results:

• No significant reduction in mean monthly headache days was observed between groups.
• The biofeedback-VR group showed a statistically significant decrease in acute analgesic use (65% reduction) compared to the control group (35% reduction).
• A significant reduction in depression scores was noted in the biofeedback-VR group (35% decrease) versus a slight increase in the control group.

Conclusions:

• Frequent use of a biofeedback-VR device may help reduce acute analgesic consumption and depressive symptoms in chronic migraine patients.
• This technology shows potential as an adjunctive treatment for chronic migraine, particularly for those seeking non-medication options.
• Further research is warranted to confirm these findings in larger populations.